Savara INC Schedule 13D activist filings

Filed when an investor crosses five percent and intends to influence the company — the activist disclosure.

NASDAQ
New Enterprise Associates and its affiliates reported a decrease in their beneficial ownership of Savara Inc. common stock to 12.0% due to an increase in the number of outstanding shares.
NASDAQ
Bain Capital Life Sciences and its affiliates have filed an Amendment No. 4 to their Schedule 13D, reaffirming their collective beneficial ownership of 9.99% of Savara Inc.'s common stock, totaling 17,600,621 shares, constrained by a beneficial ownership blocker on pre-funded warrants.